Trials / Completed
CompletedNCT07524621
The Impact of Nutrition Education and Rice Bran Supplementation on Metabolic Dysfunction-associated Steatotic Liver Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 58 (actual)
- Sponsor
- Shih Chien University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to evaluate the effects of nutrition education with or without rice bran supplementation in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Participants were recruited from the Division of Gastroenterology and Hepatology at Changhua Christian Hospital and assigned to either a nutrition education (NE) group or a nutrition education plus rice bran (NERB) group. The intervention was conducted for a specified study period, during which participants received dietary guidance and follow-up assessments. The primary objective of this study is to determine whether rice bran supplementation in addition to nutrition education provides greater benefits on body weight, body mass index, dietary intake, and metabolic parameters compared with nutrition education alone. Secondary outcomes include changes in liver-related biochemical markers, glycemic indicators, lipid profiles, and other anthropometric measurements. This study may provide evidence on the potential role of rice bran as a functional dietary supplement for improving metabolic health in patients with MASLD and may support the development of practical nutritional strategies for disease management.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Nutrition Education | Participants received structured nutrition education during the study period. |
| DIETARY_SUPPLEMENT | Rice Bran | Participants received structured nutrition education together with rice bran supplementation during the intervention period. |
Timeline
- Start date
- 2021-08-13
- Primary completion
- 2022-06-13
- Completion
- 2023-08-05
- First posted
- 2026-04-13
- Last updated
- 2026-04-13
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT07524621. Inclusion in this directory is not an endorsement.